Both in Pharmaceuticals
Mereo BioPharma Group vs Amarin
Over the past year MREO returned −83.2% and AMRN returned −25.9%; their daily moves had a correlation of 0.04.
MREO −83.2% AMRN −25.9%Growth of $1, one year, split-adjusted
| Metric | MREO | AMRN |
|---|---|---|
| Price | $0.2979 | $11.75 |
| Market cap | $47.6M | $494.0M |
| Today | +0.95% | +0.09% |
| 1 month | −5.5% | +1.9% |
| 6 months | +21.1% | −21.4% |
| Year to date | −28.5% | −15.8% |
| 1 year | −83.5% | −25.2% |
| Revenue growth (YoY) | — | −20.4% |
| Gross margin | — | 40.9% |
| Net margin | — | 0.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.8× |
| Net cash | — | $323.4M |
| Dividend yield | — | — |
| Volatility (60d) | 78.8% | 31.2% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).